시장보고서
상품코드
1255240

엑소좀 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측(2018-2028년) - 엑소좀 유형별, 소스별, 치료법별, 용도별, 최종사용자별, 지역별 부문

Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Exosome Type, By Source, By Therapy, By Application, By End User, By Region

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 113 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 엑소좀 치료 시장은 예측 기간인 2024-2028년에 안정된 CAGR로 전진할 것으로 예측됩니다.

이는 전 세계적으로 암, 심혈관 질환, 자가면역 질환과 같은 만성 질환의 유병률이 증가하고 있기 때문일 수 있습니다. 엑소좀은 화학 치료 약물, 면역 조절제, 안티센스 올리고 뉴클레오티드, 짧은 간섭 RNA(RNA), 안티센스 올리고 뉴클레오티드를 포함한 다양한 치료 페이로드를 전달하도록 설계되었습니다. 또한 암, 알츠하이머병, 파킨슨병 및 만성 심부전 치료를 위한 엑소좀 치료제의 다기능성 특성의 사용 증가로 인해 세계의 엑소좀 치료제 시장이 확대되고 있습니다. 또한 전 세계의 다양한 생명 공학 및 제약 회사와 학술 및 연구 기관에서 시작한 연구 개발 활동이 증가함에 따라 향후 세계 엑소좀 치료제 시장의 성장을 위한 수익성있는 기회가 창출될 것으로 예상됩니다. clinicaltrials.gov에 따르면 현재 전 세계적으로 다양한 개발 단계에 있는 엑소좀 치료제와 관련된 임상시험이 25건 진행 중입니다.

목차

제1장 개요

  • 시장의 정의
  • 시장의 범위
    • 대상 시장
    • 연구 대상년
    • 주요 시장 세분화

제2장 조사 방법

  • 조사 목적
  • 베이스라인 조사 방법
  • 주요 산업 파트너
  • 주요 협회와 2차 정보
  • 조사 방법
  • 데이터 삼각측량과 검증
  • 전제조건과 한계

제3장 주요 요약

  • 시장 개요
  • 주요 시장 세분화의 개요
  • 주요 시장 기업의 개요
  • 주요 지역/국가의 개요
  • 시장 촉진요인·과제·동향

제4장 VOC(고객의 소리)

제5장 임상 시험 분석

  • 진행중인 임상 시험
  • 완료한 임상 시험
  • 중지한 임상 시험
  • 파이프라인 내역(개발 단계별)
  • 파이프라인 내역(현황별)
  • 파이프라인 내역(시험 용도별)
  • 파이프라인 지역별 내역
  • 임상 시험 히트맵

제6장 세계의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별(내추럴 vs 하이브리드)
    • 소스별(중간엽 줄기세포, 혈액, 체액, 기타)
    • 치료법별(면역치료, 화학요법, 유전자 치료)
    • 용도별(대사질환, 암, 심장질환, 신경질환, 기타)
    • 최종사용자별(병원·진료소, 학술·조사기관, 기타)
    • 기업별(2022년)
    • 지역별
  • 마켓 맵

제7장 북미의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별
    • 소스별
    • 치료법별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 - 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 유럽의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별
    • 소스별
    • 치료법별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 - 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 아시아태평양의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별
    • 소스별
    • 치료법별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양의 - 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제10장 남미의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별
    • 소스별
    • 치료법별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 - 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동·아프리카의 엑소좀 치료 시장 전망

  • 시장 규모·예측
    • 수량별
  • 시장 점유율과 예측
    • 엑소좀 유형별
    • 소스별
    • 치료법별
    • 용도별
    • 최종사용자별
    • 국가별
  • MEA - 국가별 분석
    • 남아프리카공화국의 엑소좀 치료
    • 사우디아라비아의 엑소좀 치료
    • UAE에 엑소좀 치료

제12장 시장 역학

  • 촉진요인
  • 과제

제13장 시장의 동향과 개척

  • 최근 동향
  • M&A(합병·인수)
  • 제품 출시

제14장 경쟁 구도

  • Aethlon Medical, Inc.-Exosome Sciences
  • Aegle Therapeutics
  • Anjarium Biosciences AG
  • Exogenus Therapeutics SA
  • Lonza Group
  • Capricor Therapeutics, Inc.
  • Avalon Globocare Corp
  • Stem Cell Medicine Ltd.
  • Evox Therapeutics Limited
  • EV Therapeutics

제15장 전략적 제안

KSA 23.04.21

Global exosome therapeutics market is anticipated to advance at a steady CAGR in the forecast period 2024-2028. This can be ascribed due to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases across the globe. Exosomes are designed to deliver a variety of therapeutic payloads, including chemotherapeutic drugs, immunological modulators, antisense oligonucleotides, short interfering RNAs (RNAs), and antisense oligonucleotides. Also, the global exosome therapeutics market is expanding due to the rise in the usage of exosome therapy's multifunctional properties for the treatment of cancer, Alzheimer's disease, Parkinson's disease, and chronic heart failure. Besides, growing research & development activities initiated by various biotechnology & pharmaceutical companies and academic & research institutions worldwide are expected to create lucrative opportunities for the growth of the global exosome therapeutics market in the coming years. According to clinicaltrials.gov, currently, there are 25 clinical trials related to exosome therapeutics going on worldwide that are in different phases of development.

Increasing Prevalence of Chronic Diseases

The growth in the prevalence of chronic diseases, infectious diseases, autoimmune diseases, and cancer, as well as the increase in the demand for molecular diagnosis, are the main factors driving the exosome diagnostic and therapeutic market share. Additionally, ongoing developments in drug development and discovery in exosome innovation provide valuable insights into biological heterogeneity and function and improve the capacity to utilize the therapeutic and diagnostic potential for infectious disease and cancer. Therefore, the development of the exosome diagnostic and therapeutic markets is driven by technological improvement in the healthcare industry. Unhealthy eating habits, tobacco consumption, and lack of physical activity are only a few of the key causes of cardiovascular disease, which increase blood pressure and blood glucose levels, resulting in overweight and obesity which will further increase the rate of chronic diseases and demand for exosome therapeutics in the forecast period. The growing prevalence of cardiovascular illnesses has led to an increase in the need for exosome diagnostic and therapeutic products (CVDs). This is a result of the development of more durable, technologically advanced devices. According to Globocan, From the total number of 2,281,658 affected skin cancer diseases across the globe, 4.2% are affected by melanoma skin cancer, 6.8% are affected in colorectum cancer, 9.2% are affected in prostate cancer, 10% are affected in lung cancer, 11.1% are effected in breast cancer, and 58.7% are effected in other cancer.

Growing research and development

Several initiatives, such as setting up policies for the development of new therapies along with the rise in funds, are taken by governments across the world to support the healthcare industry. The government is launching different programs to provide better technology, improve treatment techniques, and improve product development and processing technologies. In addition, the rapid technological advancements in exosome therapeutics and the growth of the target patient population are also contributing to the growth in the global market over the forecast period of 2024 to 2028. According to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. In January 2020, Kimera Labs received FDA approval for the purest mesenchymal stem cell (MSC) exosomes in existence. The approval received would ensure strict compliance with good laboratory practices (GLPs) and current good manufacturing practice (CGMP) standards to enable the production of pharmaceutical-grade exosomes for investigational trials and the development of future clinical applications.

Market Segmentation

The global exosome therapeutics market is segmented into exosome type, source, therapy, application, end user, regional distribution, and competitive landscape. Based on exosome type, the market is divided into Natural exosome therapy and Hybrid exosome therapy. Based on the source, the market is divided into Mesenchymal stem cells, Blood, Body fluids, and others. Based on therapy, the market is divided into Immunotherapy, Chemotherapy, and Gene Therapy. Based on application, the market is divided into Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, and Others. Based on end users, the market is divided into hospitals & clinics, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period as the government is investing in new exosome therapeutics for the easy detection of chronic disease-unaffected people.

Market Players

Aethlon Medical, Inc.-Exosome Sciences, Aegle Therapeutics, Anjarium Biosciences AG, Exogenus Therapeutics SA, Lonza Group, Capricor Therapeutics, Inc., Avalon Globocare Corp, Stem Cell Medicine Ltd., Evox Therapeutics Limited, EV Therapeutics are some of the leading players operating in the global exosome therapeutics market.

Report Scope

In this report, global exosome therapeutics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Exosome Therapeutics Market, By Type:

  • Natural
  • Hybrid

Exosome Therapeutics Market, By Source:

  • Mesenchymal Stem Cells
  • Blood,
  • Body Fluids,
  • Others

Exosome Therapeutics Market, By Therapy :

  • Immunotherapy
  • Chemotherapy
  • Gene Therapy

Exosome Therapeutics Market, By Application:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Others

Exosome Therapeutics Market, By End User:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Others

Exosome Therapeutics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global exosome therapeutics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Exosome Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Exosome Type (Natural v/s Hybrid)
    • 6.2.2. By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others)
    • 6.2.3. By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
    • 6.2.4. By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
    • 6.2.6. By Company (2022)
    • 6.2.7. By Region
  • 6.3. Market Map

7. North America Exosome Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Exosome Type
    • 7.2.2. By Source
    • 7.2.3. By Therapy
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Exosome Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Exosome Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Therapy
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Mexico Exosome Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Exosome Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Therapy
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Canada Exosome Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Exosome Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Therapy
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Exosome Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Exosome Type
    • 8.2.2. By Source
    • 8.2.3. By Therapy
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Exosome Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Exosome Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Therapy
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Exosome Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Exosome Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Therapy
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Exosome Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Exosome Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Therapy
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Exosome Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Exosome Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Therapy
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Exosome Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Exosome Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Therapy
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Exosome Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Exosome Type
    • 9.2.2. By Source
    • 9.2.3. By Therapy
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Exosome Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Exosome Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Therapy
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Exosome Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Exosome Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Therapy
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Exosome Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Exosome Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Therapy
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Exosome Therapeutics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Exosome Type
        • 9.3.4.2.2. By Source
        • 9.3.4.2.3. By Therapy
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Exosome Therapeutics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Exosome Type
        • 9.3.5.2.2. By Source
        • 9.3.5.2.3. By Therapy
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Exosome Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Exosome Type
    • 10.2.2. By Source
    • 10.2.3. By Therapy
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Exosome Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Exosome Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Therapy
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Exosome Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Exosome Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Therapy
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Exosome Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Exosome Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Therapy
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Exosome Therapeutics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Exosome Type
    • 11.2.2. By Source
    • 11.2.3. By Therapy
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Exosome Therapeutics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Exosome Type
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Therapy
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Exosome Therapeutics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Exosome Type
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Therapy
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Exosome Therapeutics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Exosome Type
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Therapy
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (As reported)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. Aethlon Medical, Inc.-Exosome Sciences
    • 14.6.2. Aegle Therapeutics
    • 14.6.3. Anjarium Biosciences AG
    • 14.6.4. Exogenus Therapeutics SA
    • 14.6.5. Lonza Group
    • 14.6.6. Capricor Therapeutics, Inc.
    • 14.6.7. Avalon Globocare Corp
    • 14.6.8. Stem Cell Medicine Ltd.
    • 14.6.9. Evox Therapeutics Limited
    • 14.6.10. EV Therapeutics

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제